Next-generation Sequencing Market: Advancements in Genomics Driving Personalized Medicine Adoption
The Next-generation Sequencing Market Size sector reached a market value of USD 8.30 Billion in 2023. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 14.6% from 2023 to 2032. This trend is expected to culminate in a market value of USD 27.55 Billion by 2032, offering significant growth opportunities in this rapidly expanding industry. North America led the market in 2023.
Request a Free Sample PDF Brochure of Next-generation Sequencing Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101000
In its latest study, Fortune Business Insights offers an in-depth analysis of the global Next-generation Sequencing Market for the forecast period of 2024–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments.
Top Companies in the Next-generation Sequencing Market:
- Illumina Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- QIAGEN (Germany)
- PacBio (U.S.)
- Oxford Nanopore Technologies (U.K.)
- Perkin Elmer, Inc. (U.S.)
- BGI (China)
The Next-generation Sequencing Market report identifies major regions, including North America, Latin America, Europe, East Asia, and Japan, along with the most significant contributors from these regions. It includes detailed information on each key market player, including SWOT analysis, market data, market share, revenue, pricing, and gross margin.
Next-generation Sequencing Market Market Dynamics:
- Rising Adoption in Clinical Diagnostics: NGS is increasingly used for diagnosing rare diseases, hereditary disorders, and cancer, leading to improved patient outcomes and personalized treatment plans.
- Advancements in Sequencing Technology and Cost Reduction: Continuous advancements in NGS platforms, coupled with decreasing sequencing costs, expand the technology’s accessibility to a wider range of research and clinical applications.
- Growing Focus on Precision Medicine and Personalized Healthcare: NGS enables the identification of genetic variations associated with disease risk, drug response, and treatment outcomes, driving the shift towards personalized medicine.
- Expanding Applications in Research and Drug Discovery: NGS is used extensively in genomics research, drug discovery, and development, accelerating the identification of new drug targets and biomarkers.
- Data Analysis and Bioinformatics Challenges: The vast amount of data generated by NGS requires robust data analysis tools and bioinformatics expertise. Addressing these challenges is crucial for extracting meaningful insights from NGS data.
Speak to an Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/101000
Insights for each vendor include:
- Company profile
- SWOT analysis
- Key market information
- Market share
- Revenue, pricing, and gross margin
Key Insights from the Next-generation Sequencing Market Research Report:
- Macro- and microeconomic factors influencing the growth of Next-generation Sequencing Market.
- Comprehensive overview of Next-generation Sequencing Market, including market definition, classification, and applications.
- Analysis of major players based on mergers & acquisitions, R&D activities, and product launches.
- Adoption trends of Next-generation Sequencing Market across different industries.
- Regions and countries with the highest potential for Next-generation Sequencing Market stakeholders.
Regions Covered in the Next-generation Sequencing Market Report:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Table of Contents:
1. Introduction
1.1 Research Scope
1.2 Customer Segmentation
1.3 Data Collection Methods
1.4 Key Definitions & Caveats
2. Executive Summary
3. Market Dynamics
3.1 Next-generation Sequencing Market Drivers
3.2 Next-generation Sequencing Market Restraints
3.3 Market Opportunities
4. Key Insights
4.1 Value Chain Analysis
4.2 Significant M&A deals and strategic partnerships.
4.3 Covid-19 Impact
5. Healthcare Industry Trends
6. Competitive Landscape
7. Mergers, Joint Ventures, and Agreements
8. Next-generation Sequencing Market Size Growth 2024
9. Strategies Adopted by Leading Players
10. Company Profiles (Overview, Financials, Products, and Recent Developments)
11. Disclaimer
Table of Contents Continued…!
Order a copy of this report at: https://www.fortunebusinessinsights.com/checkout-page/101000
Frequently Asked Questions (FAQ’s)
- What is the market size of Next-generation Sequencing Market?
- What factors are driving Next-generation Sequencing Market growth in North America?
- Who are the major players in the Next-generation Sequencing Market?
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.
At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
